Single vs. Dual Implant Fixation for Distal Femur Fractures in Older or Compromised Adults
1 other identifier
interventional
44
1 country
2
Brief Summary
The goal of this clinical trial is to assess the feasibility of conducting a larger study comparing single implant fixation (SIF) and dual implant fixation (DIF) for treating distal femur fractures (DFF) in older or compromised adults. It will also evaluate the safety and effectiveness of these treatments. The main questions it aims to answer are:
- Can DIF improve patient outcomes compared to SIF in older or compromised adults?
- How feasible is it to recruit and retain participants for this trial? Participants will:
- Be randomly assigned to receive either SIF or DIF for their DFF treatment
- Visit the clinic for follow-ups and assessments of their recovery and bone healing, including potential ultrasound imaging for detecting complications like non-union.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2025
CompletedFirst Posted
Study publicly available on registry
April 25, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2030
September 15, 2025
September 1, 2025
1 year
March 4, 2025
September 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility Outcomes - Recruitment
Recruitment - 1) Recruitment (number of patients enrolled per-month). Success will be considered as each site enrolling a minimum mean of 0.6 patients per-month. This is a conservative estimate based on our previous trials in similar populations, and we expect that each site will screen a minimum of twice this number. * Number of patients enrolled per month * Success if each site able to enroll mean of 0.6 patients per month
Through study completion, an average of 1 year.
Feasibility Outcomes - Retention
Retention - (proportion of patients that complete one-year follow-up). Success will be considered a minimum of 85% of patients with complete one-year data. * Proportion of patients that complete 1 year follow up * Success: 85%
Through study completion, an average of 1 year.
Functional Ability
Via the validated Oxford Knee Score. It ranges from 0 to 48, with higher scores indicating better outcomes (i.e., less pain and better function).
2 year
Secondary Outcomes (15)
Pain rating
2 years
Functional ability
2 years
Weight-bearing
2 years
Mobility
3, 6, 12 and 24 months.
Health-related quality of life (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression).
2 years
- +10 more secondary outcomes
Study Arms (2)
Group A (Control): Single Implant Fixation (SIF)
ACTIVE COMPARATORPatients in this arm will undergo fixation of distal femur fractures using a single implant, which could be a lateral locked plate or a retrograde intramedullary nail.
Group B (Experimental): Dual Implant Fixation (DIF)
ACTIVE COMPARATORPatients in this arm will undergo fixation using dual implants, either dual plate fixation or a combination of nail and plate fixation.
Interventions
This intervention involves using one implant for fracture fixation. The implant can be either a lateral locked plate or a retrograde intramedullary nail, based on the surgeon's preference.
This intervention involves using two implants for fracture fixation. The combination can be either dual plate fixation (DPF) or combination nail plate fixation (NPF) .
Eligibility Criteria
You may qualify if:
- Isolated DFF (native AO/OTA-type A2, A3, C or periprosthetic Lewis and
- Rorabeck type 1, 2) and either:
- Age ≥ 60 years or;
- Age 18-60 years with one or more of:
- i. Osteoporosis ii. Obesity (Body Mass Index \>30) iii. Metaphyseal comminution iv. Diabetes
- Fracture amenable to plating and nailing
- Ability to read and speak English or availability of a translator
- Acute fractures (within 14-days of injury)
- No surgeon preference regarding SIF vs. DIF
- Provision of informed consent
You may not qualify if:
- Candidate for primary or revision arthroplasty (surgeon opinion)
- Periprosthetic fracture with loose implant
- Gustillo grade III open fractures
- Ipsilateral hip implant
- Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e., no fixed address, mentally competent to give consent, etc.)
- Non-ambulatory patients
- Multi-trauma patient (Injury Severity Score ≥ 16)
- Lack of bone substance or poor bone-quality which, in the surgeon's judgment, makes fixation impossible
- Any concomitant lower-extremity injury
- Inability to obtain informed consent due to language barrier
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Fraser Orthopaedic Institute
New Westminster, British Columbia, Canada
London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2025
First Posted
April 25, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
May 1, 2030
Last Updated
September 15, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share